Scarica l'app Stockscreener
0.078
3.17%
0.0024
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Prophase Labs Inc Borsa (PRPH) Ultime notizie
ProPhase Labs, Inc. (PRPH) Q1 2026 10-Q: Financials, Stock Info, and Key SEC Filing Details - Minichart
ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q Summary - TradingView
ProPhase Labs (PRPH) flags going concern risk after Q1 2026 loss and heavy financing - Stock Titan
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Price to sales forward of ProPhase Labs, Inc. – OTC:PRPH - TradingView
ProPhase Labs, Inc. Actuals & Estimates (OTC:PRPH) - TradingView
Prophase Labs Inc (PRPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ProPhase Labs StockLong-term business model and market position - AD HOC NEWS
Prophase Labs Inc (PRPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Prophase Labs Inc (PRPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Prophase Labs Inc (PRPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Prophase Labs Inc (PRPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Prophase Labs Inc (PRPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ProPhase Labs, Inc. 2025 Annual Report: Genomics, Biotech, Diagnostics, and Supplement Innovations Overview - Minichart
ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K Summary - TradingView
[10-K] ProPhase Labs, Inc. Files Annual Report - Stock Titan
ProPhase Labs, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
MSN Money - MSN
PRPH | PROPHASE LABS INC Insider Trading - Quiver Quantitative
ProPhase Labs stock (US74345W1080): earnings update and shifting focus beyond COVID testing - AD HOC NEWS
ProPhase Labs Delays Quarterly Financial Filing - TipRanks
ProPhase Labs (NASDAQ: PRPH) delays Q1 2026 10-Q amid 2025 audit - Stock Titan
ProPhase Labs stock (US74345W1080): Reverse stock split raises questions - AD HOC NEWS
TradingKey - TradingKey
Prophase Labs Stock Price Forecast. Should You Buy PRPH? - StockInvest.us
ProPhase Testing Units Creditor Says No Real Ch. 11 Progress - Law360
PROPHASE LABS INC by ProPhase Labs, Inc. Analyst Ratings and Price Targets | OTC:PRPH - Benzinga
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ProPhase Labs earnings missed by $2.47, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform - The Manila Times
ProPhase Labs Reports Year-End 2025 Results, Highlights - GlobeNewswire
Geopolitics Watch: What analysts say about ProPhase Labs Inc stock2026 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn
ETF Watch: Is ProPhase Labs Inc exposed to political riskMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Street Watch: Is ProPhase Labs Inc exposed to currency risksRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Earnings Update: How much upside does ProPhase Labs Inc have2026 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEARTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn
Nasdaq Moves: Will ProPhase Labs Inc benefit from AI trends2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Market Review: Whats next for ProPhase Labs Inc stock2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
ProPhase Labs (NASDAQ:PRPH) versus Medicure (OTCMKTS:MCUJF) Financial Contrast - Defense World
ProPhase Labs, Inc. (PRPH) stock price, news, quote and history - Yahoo Finance UK
Risk Hedge: Is ProPhase Labs Inc exposed to political risk2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Quarterly Risk: How does ProPhase Labs Inc score in quality rankings2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
ProPhase Labs Delays Annual 10-K Yearly Filing - TipRanks
ProPhase Labs (PRPH) notifies SEC of delayed FY2025 10-K; expects 15-day filing - Stock Titan
Guidance Update: Is ProPhase Labs Inc exposed to political risk2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: What analysts say about ProPhase Labs Inc stockIndex Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Investment Recap: How much upside does ProPhase Labs Inc have2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Gains Report: What analysts say about ProPhase Labs Inc stockQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ProPhase Labs (PRPH) Updates on Crown Medical Collections Progre - GuruFocus
ProPhase Labs provides business update highlighting advancing Crown Medical collections activity - marketscreener.com
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - The Manila Times
Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - TradingView
Biotech seeks insurer recoveries from 250+ payors for receivables-backed cash - Stock Titan
Big Picture: What analysts say about ProPhase Labs Inc stockQuarterly Growth Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Financial Analysis: ProPhase Labs (NASDAQ:PRPH) versus Ono Pharmaceutical (OTCMKTS:OPHLF) - Defense World
Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
0.14%
0.62%
Capitalizzazione:
|
Volume (24 ore):